FDA Investigator Pradip N Akolkar
Pradip N Akolkar has conducted inspections on 3 sites in 3 countries as of 27 Jan 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
3
Last Inspection Date:
27 Jan 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
Singapore,
United States of America,
Ireland
FDA Investigators that have inspected at least one site in common with Pradip N Akolkar:
Althea A Williams,
Andrew A Leboeuf,
Brian D Nicholson,
Burnell M Henry,
Christopher D Leach,
David J Gasparovich,
Dolores Harper,
James W Plucinski,
Jesse A Vazquez,
Joseph A Morkunas,
Karen Emasley Joseph,
Kathleen B Swat,
Kimberly Lewandowski Walker,
Lequita M Mayhew,
Nicholas Z Lu,
Nicole S Williams,
Omotunde O Osunsanmi,
Paola S Barnett,
Shafiq S Ahadi,
Susan D Yuscius,
That Q Dang
Pradip N Akolkar's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2007 | FDA 483 | Abbott Molecular, Inc. - Form 483, 2007-02-21 |
February, 2007 | EIR | Abbott Molecular, Inc. - EIR, 2007-02-21 |
September, 2003 | EIR | Trinity Biotech Plc - EIR, 2003-09-18 |
August, 2013 | FDA 483 | MP Biomedicals Asia Pacific Ptd Ltd - Form 483, 2013-08-22 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more